Semaglutide for alcoholism

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 6 registered trials.

Why this status

  1. 20 Oct 2025: Trial registered, NCT07218354
  2. 28 Jul 2026: Trial started, NCT07218354

The trials

NCT05520775: Semaglutide for Alcohol Use Disorder

State
Completed
Phase
Phase 2
People
48 taking part
Started
2 Sep 2022
Primary completion
12 Apr 2024
Arms
Semaglutide
Results
Posted on the registry
Papers
doi:10.1001/jamapsychiatry.2024.4789
  1. 30 Aug 2022: Trial registered
  2. 2 Sep 2022: Trial started
  3. 19 Apr 2024: Trial completed
  4. 24 Mar 2025: Trial results posted

NCT05891587: Semaglutide Therapy for Alcohol Reduction - Tulsa

State
Completed
Phase
Phase 2
People
80 taking part
Started
7 Jul 2023
Primary completion
30 Jul 2025
Arms
Semaglutide
Results
None posted
  1. 7 Jun 2023: Trial registered
  2. 7 Jul 2023: Trial started
  3. 1 Oct 2025: Trial completed

NCT06015893: Semaglutide Therapy for Alcohol Reduction (STAR)

State
Under way
Phase
Phase 2
People
63 taking part
Started
17 Oct 2023
Primary completion
31 Mar 2027
Arms
Semaglutide
Results
None posted
  1. 29 Aug 2023: Trial registered
  2. 17 Oct 2023: Trial started

NCT07040592: Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide

State
Under way
Phase
Phase 2
People
30 planned
Started
15 Jan 2026
Primary completion
30 Jun 2027
Arms
Semaglutide
Results
None posted
  1. 27 Jun 2025: Trial registered
  2. 15 Jan 2026: Trial started

NCT07218354: Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)

State
Under way
Phase
Phase 3
People
622 planned
Started
28 Jul 2026
Primary completion
31 Mar 2029
Arms
Semaglutide
Results
None posted
  1. 20 Oct 2025: Trial registered
  2. 28 Jul 2026: Trial started

How the status changed

  1. 16 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Arm 2 - DehydraTECH-semaglutide alone, Ozempic, Rybelsus, Semaglutide (Wegovy®), Semaglutide 1.0 mg, Semaglutide 2.4 mg, Semaglutide Injectable Product, Semaglutide Injectable Product (Wegovy and/or Ozempic), Semaglutide Pen Injector, Semaglutide, 1.34 mg/mL, Wegovy.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.